Finding. HIF-1α is the switch that decides whether intestinal RORγt+ regulatory T cells stay suppressive or turn inflammatory, and mitochondria are part of the switch. Delete Hif1a in RORγt-expressing cells and mice are protected in chemical colitis, T-cell-transfer colitis, and colitis-associated cancer. Give lymphopenic mice the same bad naïve T cells and change only the cotransferred Treg genotype, and protection still tracks the knockout Tregs. Those Tregs secrete more IL-10, less IL-17A and IFN-γ, suppress better, and look mitochondrially fitter: fewer dysfunctional and mtROS-high organelles, more fusion-associated transcription, higher basal and maximal oxygen consumption and reserve.
Why this paper matters
Gut Tregs that express RORγt sit on a knife edge between regulation and an inflammatory, RORγt-high fate. Cipelli, da Silva, Menezes-Silva and Camara connect that edge to hypoxia transcription and to mitochondrial fitness, then test it in three in vivo models. The human ileal reanalysis (Crohn’s-enriched FOXP3 states stacking RORC, HIF1A, hypoxia, inflammatory, and metabolic programs) is why this is not only a mouse cytokine paper.
For mitochondria, the point is not that Tregs “use OXPHOS.” It is that HIF-1α correlates with a sloppier, ROS-high mitochondrial set and that losing HIF-1α restores OCR and reserve while restoring suppression.
What they actually measured
Human ileal single-cell reanalysis. Mouse genetics: Hif1a in RORγt-expressing cells. In vivo: DSS, transfer colitis, AOM/DSS CAC. A cotransfer that isolates Treg function. Cell-intrinsic: IL-10 up, IL-17A/IFN-γ down, suppression, mtROS/dysfunction, fusion transcription, basal/maximal OCR and reserve. During CAC, fewer inflammatory RORγt+ Tregs and lower tumor burden. Human trajectory and gene-regulatory-network predictions that HIF1A perturbation would oppose some disease branches.
RORγt-Cre is not Treg-Cre. The cotransfer is the cleanest functional pin. OCR is a Seahorse-style claim, not a mucosal oxygen map.
How to read the score
Around 80. Three in vivo models, a Treg-intrinsic mitochondrial package, and a human computational echo. Confidence is medium. Score 80.
What to do with it
Track if you work on Treg metabolism, intestinal hypoxia, or colitis-associated cancer immunity. Pull the OCR/mtROS panels and the cotransfer curves. Do not recommend a HIF inhibitor for Crohn’s disease from this brief. The directional implication is that HIF-1α couples hypoxia transcription to mitochondrial slack and inflammatory plasticity in gut RORγt+ Tregs.